3.4.21.B39	ascites fluid	from ovarian cancer patients	647355	
3.4.21.B39	bone marrow	expression	670978	
3.4.21.B39	bone marrow	low expression	670977	
3.4.21.B39	brain	-	647353	
3.4.21.B39	brain	high expression level	647332	
3.4.21.B39	brain	lexpression	670978	
3.4.21.B39	breast	-	680680	
3.4.21.B39	breast	expression levels of KLK5 and KLK7 in benign breast tissues and metastases, and the relationship between KLK5 and KLK7 expression and and clinicopathological factors. mRNA levels of KLK5 and KLK7 in normal breast tissues, benign breast tissues, primary tumors, and lymph node metastases, overview. mRNA levels of KLK5 and KLK7 are both downregulated in breast cancers relative to normal and benign tissues, and downregulated in metastases compared to primary cancers	707996	
3.4.21.B39	breast	high expression	670978	
3.4.21.B39	breast	high expression level	647332